Cost-effectiveness of cervical cancer screening with primary human papillomavirus testing in Norway

E A Burger; J D Ortendahl; S Sy; I S Kristiansen; J J Kim

首页> 外文期刊>British Journal of Cancer >Cost-effectiveness of cervical cancer screening with primary human papillomavirus testing in Norway

【24h】

Cost-effectiveness of cervical cancer screening with primary human papillomavirus testing in Norway

机译：在挪威通过原发性人乳头瘤病毒检测进行子宫颈癌筛查的成本效益

获取原文

获取外文期刊封面目录资料

开具论文收录证明 >>

文献代查 >>

文献数据库（团队版） >>

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

Background:New screening technologies and vaccination against human papillomavirus (HPV), the necessary cause of cervical cancer, may impact optimal approaches to prevent cervical cancer. We evaluated the cost-effectiveness of alternative screening strategies to inform cervical cancer prevention guidelines in Norway.

机译：背景：新的筛查技术和针对人乳头瘤病毒（HPV）的疫苗接种是宫颈癌的必要病因，可能会影响预防宫颈癌的最佳方法。我们评估了替代筛查策略的成本效益，以指导挪威的子宫颈癌预防指南。

著录项

来源
《British Journal of Cancer》 |2012年第9期|共8页
作者
E A Burger; J D Ortendahl; S Sy; I S Kristiansen; J J Kim;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Human papillomavirus testing versus cytology in primary cervical cancer screening: End-of-study and extended follow-up results from the Canadian cervical cancer screening trial [J] . Isidean Sandra D., Mayrand Marie-Helene, Ramanakumar Agnihotram V., International Journal of Cancer =: Journal International du Cancer . 2016,第11期

机译：人类乳头瘤病毒测试与细胞学检查在原发性子宫颈癌筛查中的应用：加拿大子宫颈癌筛查试验的研究结束和扩展的随访结果
2. Human papillomavirus testing versus cytology in primary cervical cancer screening: End-of-study and extended follow-up results from the Canadian cervical cancer screening trial [J] . Isidean Sandra D., Mayrand Marie-Helene, Ramanakumar Agnihotram V., International Journal of Cancer =: Journal International du Cancer . 2016,第11期

机译：人乳头瘤病毒检测与初级宫颈癌筛查中的细胞学：研究结束和加拿大宫颈癌筛查试验的延长后续结果
3. Not all HPV nucleic acid tests are equal: only those calibrated to detect high grade lesions matter for cervical screening: Response to 'Concordant testing results between various human papillomavirus assays in primary cervical cancer screening: systematic review' by de Thurah, Bonde, Uyen, Lam and Rebolj. Published 27 May, 2017 [J] . de Thurah L., Bonde J., Lam J. U. H., Clinical microbiology and infection: European Society of Clinical Microbiology and Infectious Diseases . 2018,第4期

机译：并非所有HPV核酸试验相等：只校准的那些才能检测宫颈筛查的高级病变物质：反应对原发性宫颈癌筛查中各种人乳头瘤病毒测定的“协调测试结果：系统评论”由De Thurah，Bende，Uyen，UYEN，林和雷罗尔赫。 2017年5月27日出版
4. Human Papillomavirus Testing in Primary Screening of High-Grade Cervical Lesions: A Study of 12538 Women [C] . C. Clavel, J. Cucherousset, J.P. Bory, International Multidisciplinary Congress . 2003

机译：高档宫颈病变初级筛查人乳头瘤病毒检测：12538名女性的研究
5. Intention of women to receive cervical cancer screening in the era of human papillomavirus testing. [D] . Ogilvie, Gina Suzanne. 2012

机译：在人类乳头瘤病毒检测时代，女性有意接受子宫颈癌筛查。
6. Cost-effectiveness of cervical cancer screening with primary human papillomavirus testing in Norway [O] . E A Burger, J D Ortendahl, S Sy, 2012

机译：在挪威通过原发性人乳头瘤病毒检测进行子宫颈癌筛查的成本效益
7. RF4 Cost-Effectiveness of Various Combinations of Human Papillomavirus (HPV)-Based Primary Screening Testing, Including Genotyping for HPV 16/18, for Cervical Cancer Screening in Mexico [O] . Corro A., Ramirez A., Williams E., 2013

机译：基于人乳头瘤病毒（HPV）的各种组合的RF4成本-效果的初步筛选测试，包括HPV 16/18的基因分型，用于墨西哥宫颈癌的筛选

Cost-effectiveness of cervical cancer screening with primary human papillomavirus testing in Norway

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅